New Owner
AstraZeneca - Takeda Respiratory Business
AstraZeneca acquires Takeda Respiratory Business
Announced: April 16, 2016
Closed: May 09, 2016
Type: Acquisition
Disposition: Combined
Terms: Cash
Status: Complete
Amount: $ 575,000,000